Abstract
About 10 years ago nobody would have believed that cell therapy would become one of the future promises of therapy, and human cells one of the hopes for the cure of emerging diseases not treatable with conventional drugs. The advent and potentiality of stem cells and other types of cells as drugs is revolutionizing the production and regulatory fields. Producer and regulators alike have to be prepared to face with this new concept of therapeutics in terms of cell expansion related to the lot definition, bioreactor used, safety and QC tests for lot release. Here we describe a new process for the GMP manufacturing of human T lymphocytes not HLA restricted, for Phase I and Phase II clinical trials of different types of tumors. The process is based on the use of the modular and disposable bioreactor Cell Factory and was conceived to maximize the potentiality of the bioreactor related to the physiology of the cells. All the steps of the process from MCB thawing to the bags filling are discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
O'Connors R., Cesano A., Lange B., Finan J., Nowell P.C, Clark S.C., Raimondi S.C., Rovera G. and Santoli D., 1991, Growth factor requirements of childhood acute Tlymphoblastic leukaemia: correlation between presence of chromosomal abnormalities and ability to grow permanently in vivo. Blood 77: 1534–1546
Cesano A., Visonneau S., Jeglum K.A., Owen J., Wilkinson K., Carner K., Reese L., and Santoli D., 1996, Phase I clinical trial with a human major histocompatibility complex nonrestricted cytotoxic t-cell line (Tall-104) in dogs. 56, 3021–3029, 1996
PCT/ EP 03/11024 — Procedure for the scale-up of T-Lymphocytes in an homogeneous system. Trasciatti S, Nolli M L, Cavenaghi L, De Bernardi Nadia
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this paper
Cite this paper
Bernardi, N.D. et al. (2007). Manufacturing of Lots of Human T-Lymphocytes for Cell Therapy. In: Smith, R. (eds) Cell Technology for Cell Products., vol 3. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-5476-1_132
Download citation
DOI: https://doi.org/10.1007/978-1-4020-5476-1_132
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-5475-4
Online ISBN: 978-1-4020-5476-1
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)